Cardlytics Q1 2022 Earnings Report
Key Takeaways
Cardlytics reported a strong Q1 2022 with revenue of $67.9 million, a 28% increase year-over-year. The company achieved net income attributable to common stockholders of $33.0 million, or $0.91 per diluted share, compared to a net loss of $(24.9) million, or $(0.85) per diluted share in the first quarter of 2021.
Revenue increased by 28% year-over-year to $67.9 million.
Billings increased by 29% year-over-year to $98.2 million.
Net income attributable to common stockholders was $33.0 million, or $0.91 per diluted share.
Cardlytics MAUs increased by 6% year-over-year to 178.5 million and ARPU increased by 13% year-over-year to $0.36.
Cardlytics
Cardlytics
Forward Guidance
Cardlytics anticipates billings to be between $106.0 million and $116.0 million, revenue to be between $73.0 million and $80.0 million, and adjusted contribution to be between $36.5 million and $40.5 million for the second quarter of 2022.